Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvana A M Urru

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Human Vaccines & Immunotherapeutics|July 1, 2021
Safety of Sars-Cov-2 vaccines administration for adult patients with hereditary fructose intoleranceSilvana A M Urru, Evelina Maines, Annalisa Campomori, et al.
Rapid Communications in Mass Spectrometry : RCM|March 21, 2007
2-substituted benzofuran fragment ion formation in the electron ionization mass spectra of 6-alkyl- and 6-aryldibenzo(d,f)(1,3)dioxepine derivatives. 1. Spirocyclization of the molecular ions in the gas phaseMichela Begala, Graziella Tocco, Gabrielle Meli, et al.
Journal of Mass Spectrometry : JMS|October 15, 2008
Formation of 2-substituted benzofuran fragment ions from 6-alkyl- and 6-aryldibenzo(d,f)(1,3)dioxepine derivatives under electron ionization-a useful precursor ion for isomeric differentiationMichela Begala, Graziella Tocco, Gabriele Meli, et al.
Scientific Reports|March 17, 2021
Safety of switching between rituximab biosimilars in onco-hematologySilvana A M Urru, Stefania Spila Alegiani, Anna Guella, et al.
International Journal of Clinical Pharmacy|February 6, 2026
Correction: Behavioural theories, models and frameworks to underpin clinical pharmacy and pharmacy practice research: guidance from the European Society of Clinical PharmacyAnita E Weidmann, Cathal Cadogan, Daniela Fialová, et al.
International Journal of Clinical Pharmacy|July 21, 2025
Behavioural theories, models and frameworks to underpin clinical pharmacy and pharmacy practice research: guidance from the European Society of Clinical PharmacyAnita E Weidmann, Cathal Cadogan, Daniela Fialová, et al.
Cancers|October 16, 2024
The Importance of Real-World Data in Evaluating the Safety of Biosimilars: A Descriptive Study of Clinical Practice in an Oncohematological Italian PopulationSilvana A M Urru, Flavia Mayer, Stefania Spila Alegiani, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 1, 2026
Real-world evaluation of health-related quality of life in hematology patients treated with rituximab: results of a multicentric cross-sectional cohort studySilvana A M Urru, Flavia Mayer, Stefania Spila Alegiani, et al.
Journal of Medicinal Chemistry|October 2, 2010
A new fluorogenic peptide determines proteasome activity in single cellsSilvana A M Urru, Pietro Veglianese, Ada De Luigi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 1, 2018
Kidney size in relation to ageing, gender, renal function, birthweight and chronic kidney disease risk factors in a general populationDoloretta Piras, Marco Masala, Alessandro Delitala, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Human Vaccines & Immunotherapeutics|July 1, 2021
Safety of Sars-Cov-2 vaccines administration for adult patients with hereditary fructose intoleranceSilvana A M Urru, Evelina Maines, Annalisa Campomori, et al.
Rapid Communications in Mass Spectrometry : RCM|March 21, 2007
2-substituted benzofuran fragment ion formation in the electron ionization mass spectra of 6-alkyl- and 6-aryldibenzo(d,f)(1,3)dioxepine derivatives. 1. Spirocyclization of the molecular ions in the gas phaseMichela Begala, Graziella Tocco, Gabrielle Meli, et al.
Journal of Mass Spectrometry : JMS|October 15, 2008
Formation of 2-substituted benzofuran fragment ions from 6-alkyl- and 6-aryldibenzo(d,f)(1,3)dioxepine derivatives under electron ionization-a useful precursor ion for isomeric differentiationMichela Begala, Graziella Tocco, Gabriele Meli, et al.
Scientific Reports|March 17, 2021
Safety of switching between rituximab biosimilars in onco-hematologySilvana A M Urru, Stefania Spila Alegiani, Anna Guella, et al.
International Journal of Clinical Pharmacy|February 6, 2026
Correction: Behavioural theories, models and frameworks to underpin clinical pharmacy and pharmacy practice research: guidance from the European Society of Clinical PharmacyAnita E Weidmann, Cathal Cadogan, Daniela Fialová, et al.
International Journal of Clinical Pharmacy|July 21, 2025
Behavioural theories, models and frameworks to underpin clinical pharmacy and pharmacy practice research: guidance from the European Society of Clinical PharmacyAnita E Weidmann, Cathal Cadogan, Daniela Fialová, et al.
Cancers|October 16, 2024
The Importance of Real-World Data in Evaluating the Safety of Biosimilars: A Descriptive Study of Clinical Practice in an Oncohematological Italian PopulationSilvana A M Urru, Flavia Mayer, Stefania Spila Alegiani, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 1, 2026
Real-world evaluation of health-related quality of life in hematology patients treated with rituximab: results of a multicentric cross-sectional cohort studySilvana A M Urru, Flavia Mayer, Stefania Spila Alegiani, et al.
Journal of Medicinal Chemistry|October 2, 2010
A new fluorogenic peptide determines proteasome activity in single cellsSilvana A M Urru, Pietro Veglianese, Ada De Luigi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 1, 2018
Kidney size in relation to ageing, gender, renal function, birthweight and chronic kidney disease risk factors in a general populationDoloretta Piras, Marco Masala, Alessandro Delitala, et al.
Pageof 2